Clinical Trials Directory

Trials / Completed

CompletedNCT02745613

Type 2 Diabetes Affect Exercise Induced Improvement in Insulin Sensitivity

Does a Family History of Type 2 Diabetes Affect Exercise Induced Improvement in Insulin Sensitivity in a Hispanic Population?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
University of Texas, El Paso · Academic / Other
Sex
Male
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study investigates weather a family history of type 2 diabetes affects exercise induced improvements in insulin sensitivity in the hispanic population

Detailed description

A family history of T2D (FH+) is a risk factor for developing insulin resistance (which precedes T2D) and T2D (Ryder et al., 2003). Exercise training on the other hand has been shown to improve insulin sensitivity and is highly effective to prevent/manage T2D. However it is not known if early signs of insulin resistance appear before being clinically diagnosed and if the benefits of exercise which prevent/cure T2D, are limited to the offspring of Hispanic T2D parents. Therefore, the proposed study will determine 1) if normoglycemic (normal blood glucose) offspring of T2D parents are insulin resistant, using the gold standard method to measure insulin sensitivity and metabolic flexibility (ability to switch between carbohydrate and fat oxidation) 2) if 8 weeks of exercise training improves insulin sensitivity and metabolic flexibility to the same extent in FH+ compared to normoglycemic offspring of parents without any history of T2D (FH-) and 3) if 8 weeks of exercise training will change the blood, lipid and molecular profiles relevant to insulin sensitivity to same extent in FH+ compared to offspring of parents without family history of T2D (FH-).

Conditions

Interventions

TypeNameDescription
OTHER8 weeks of combined exercise interventionThe subjects will undergo an 8 week combined exercise intervention

Timeline

Start date
2016-04-01
Primary completion
2019-05-01
Completion
2019-05-01
First posted
2016-04-20
Last updated
2020-01-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02745613. Inclusion in this directory is not an endorsement.